PatientID	DAS28	SDAI	Group	Drug
RAa-1-1	5.09	26.76	RA-BT	TOF
RAa-1-2	5.29	28.6	RA-BT	TOF
RAa-1-3	5.19	29.64	RA-BT	ADA
RAa-1-4	4.68	23.15	RA-BT	TOF
RAa-1-5	4.72	23.55	RA-BT	ADA
RAa-1-6	4.39	16.91	RA-BT	TOF
RAa-1-7	5.04	26.39	RA-BT	None
RAa-1-8	4.39	20.03	RA-BT	ADA
RAa-1-9	5.57	32.83	RA-BT	TOF
RAa-1-10	4	16.36	RA-BT	ADA
RAa-1-11	3.83	15.024	RA-BT	None
RAa-1-12	4.24	23.3	RA-BT	ADA
RAa-1-13	5.07	26.76	RA-BT	TOF
RAa-1-14	5.68	40.3	RA-BT	TOF
RAa-1-15	3.83	17.13	RA-BT	ADA
RAa-1-16	4.69	23.87	RA-BT	TOF
RAa-1-17	4.67	22.1	RA-BT	None
RAa-1-18	2.63	4.573	RA-BT	None
RAa-1-19	6.68	51.1	RA-BT	ADA
RAa-1-20	6.6	51.3	RA-BT	ADA
RAa-1-21	4.59	21.11	RA-BT	TOF
RAa-1-22	5.91	45.05	RA-BT	ADA
RAa-1-23	6.48	56.589	RA-BT	TOF
RAa-1-24	5.02	25.12	RA-BT	TOF
RAa-1-25	3.67	10.833	RA-BT	None
RAa-1-26	2.44	6.083	RA-BT	None
RAa-1-27	2.1	3.24	RA-BT	None
RAa-1-28	5.59	33.317	RA-BT	TOF
RAa-1-29	4.93	25.437	RA-BT	None
RAa-1-30	5.42	31.16	RA-BT	ADA
RAa-1-31	4.92	25.808	RA-BT	TOF
RAa-1-33	6.16	46.885	RA-BT	ADA
RAa-1-34	5.02	25.61	RA-BT	TOF
RAa-1-35	5.04	30.566	RA-BT	None
RAa-1-36	6.86	55.2	RA-BT	TOF
RAa-1-37	5.88	37	RA-BT	ADA
RAa-1-40	4.08	18.566	RA-BT	None
RAa-1-1	4.57	18.92	RA-AT	TOF
RAa-1-2	3.78	19.5	RA-AT	TOF
RAa-1-3	4.44	20.674	RA-AT	ADA
RAa-1-4	2.74	6.523	RA-AT	TOF
RAa-1-5	2.97	6.67	RA-AT	ADA
RAa-1-6	2.93	9.143	RA-AT	TOF
RAa-1-8	2.71	6.17	RA-AT	ADA
RAa-1-9	NA	NA	RA-AT	TOF
RAa-1-10	3.79	12.86	RA-AT	ADA
RAa-1-12	2.65	6.384	RA-AT	ADA
RAa-1-13	4.63	19.64	RA-AT	TOF
RAa-1-14	4.59	19.62	RA-AT	TOF
RAa-1-15	5.46	32.73	RA-AT	ADA
RAa-1-16	2.5	4.37	RA-AT	TOF
RAa-1-19	4.65	20.42	RA-AT	ADA
RAa-1-20	3.61	10.6	RA-AT	ADA
RAa-1-21	2.83	5.09	RA-AT	TOF
